Merit Medical Systems (MMSI) Fell Due to Tariff and Trade Policy Concerns

Core Insights - Loomis Sayles Small Cap Growth Fund reported a return of 9.37% for Q2 2025, underperforming the Russell 2000 Growth Index which returned 11.97% due to security selection issues in the information technology and financial sectors [1] Company Overview - Merit Medical Systems, Inc. (NASDAQ:MMSI) is a manufacturer of single-use medical products, focusing on interventional cardiology and radiology [2][3] - As of September 29, 2025, Merit Medical's stock closed at $80.86 per share, with a market capitalization of $4.788 billion [2] Financial Performance - In Q2 2025, Merit Medical reported revenues of $382.5 million, reflecting a 13% year-over-year increase on a GAAP basis and a 12.5% increase on a constant currency basis [4] Market Position - Merit Medical is not among the 30 most popular stocks among hedge funds, with 26 hedge fund portfolios holding the stock at the end of Q2 2025, an increase from 24 in the previous quarter [4] - The company faces challenges due to tariff and trade policy concerns, as approximately 40% of its revenues are generated outside the US [3]